ME/CFS is a long-term physical illness whose defining feature is post-exertional malaise: even small amounts of physical or mental effort can trigger a delayed crash that lasts for days. That one fact reshapes the whole approach to care. Graded exercise therapy, once standard, was withdrawn by the 2021 UK guideline after evidence that it could make people worse.
The current mainstay is pacing: learning to live within your available energy so you crash less often. Pacing does not cure the illness, and no drug has changed its course in a trial, so daily care is steady symptom management for unrefreshing sleep, the dizziness and racing heart of orthostatic problems, and pain, each treated on its own terms.
Practice Ranking
Every practice we track for Chronic Fatigue Syndrome (ME/CFS), ranked by how well the evidence supports it for this condition. Strength describes the evidence, not our endorsement.
3 practices · 1 to start with
| # | Practice | Evidence | Type | Cost | Effort | Results In | Add to plan |
|---|---|---|---|---|---|---|---|
| 1 | Pacing The frontline approach: stay within your energy envelope to avoid post-exertional crashes. Management, not a cure. | Moderate | Self-Directed | – | – | – | |
| 2 | Cognitive Behavioral Therapy Supportive CBT can help some people cope, alongside pacing; it is not a cure and remains contested in the patient community. | Emerging | Self-Directed | Free to $$ | Moderate to Hard | Weeks | |
| 3 | Coenzyme Q10 Coenzyme Q10 plus NADH lowered exercise heart rate and eased fatigue over 8 weeks in one 80-person trial. | Preliminary | Supplement | $ to $$ | Easy | Weeks to Months | |
Default order puts the best-supported practices first, with self-directed care ahead of clinical options. Click any row to open the practice.
This page is about ME/CFS, the illness whose defining feature is a crash after exertion. For everyday tiredness and the many other things that cause it, see Fatigue. Where the illness began after a COVID infection, the overlap is close, and Long COVID covers that ground alongside this page.
What It Is
Myalgic encephalomyelitis, also called chronic fatigue syndrome, is a long-term physical illness marked by disabling fatigue that rest does not fix. One feature sets it apart from ordinary tiredness: post-exertional malaise, a delayed and disproportionate crash that follows even small physical or mental effort, often a day or two later, and can last for days or weeks. It is why the usual advice to push through backfires, and it shapes every other decision about care.
There is no single blood test. A doctor recognizes ME/CFS by its pattern:
- months of fatigue that does not lift with rest,
- the crash after exertion,
- unrefreshing sleep,
- trouble with memory, concentration, or standing upright.
The diagnosis is made after other causes are ruled out, so an early, careful assessment matters. It catches treatable conditions like thyroid disease or sleep apnea, and it settles the diagnosis with confidence.
Severity runs across a wide range:
- Mild: activity is cut by around half. Many people keep working or studying by giving up leisure, social life, and rest margins, then crash after any overexertion.
- Moderate: most people are housebound, managing daily tasks only in short bursts with rest between.
- Severe and very severe: people are largely or entirely bed-bound, often unable to tolerate light, sound, or being moved, and may need help with eating and washing. Exertions that look trivial can cause a lasting setback. This most severely affected group is often under-recognized.
Many people with ME/CFS also feel worse upright, with light-headedness, dizziness, and a racing heart that eases on lying down. This overlaps with postural tachycardia syndrome, or POTS, a form of orthostatic intolerance that is treatable in its own right. ME/CFS is not rare, and it affects women more often than men.
What Helps
Care for ME/CFS has an order, and it starts with living inside your energy limit.
Pacing comes first. Pacing, also called energy management, means learning where your limit sits and staying inside it, so effort does not tip you into a crash. It is not resting all day. It does not cure the illness; it lowers how often you crash and makes a fluctuating illness more livable. In large patient surveys it is the approach people rate most helpful and least likely to set them back, which is why current guidance builds care around it. A large trial has not yet tested individualized pacing head to head, so it rests on patient experience and current guidance. The structured pacing program tested in the PACE trial is a separate thing, a fixed protocol that did no better than usual specialist care, and it should not be confused with day-to-day energy management. The practical core is learning your own early warning signs and stopping before you reach the limit.
The exercise question needs care, because getting it wrong has harmed people. For years, graded exercise therapy, a program of steadily increasing activity, was standard, built on the PACE trial. A Cochrane review still finds a small fatigue benefit on low-to-moderate-certainty evidence. Two findings weighed more heavily in current guidance: large patient surveys reporting high rates of harm from graded exercise, and a reanalysis of PACE by its own original protocol showing the recovery claims were far smaller than first reported and no better than the comparison group. Most of the trials behind the benefit signal also enrolled people under broad criteria that did not require post-exertional malaise, so they may not describe those for whom exertion reliably triggers a crash. Weighing the harm reports against the deflated recovery claims, the 2021 UK national guideline withdrew graded exercise therapy, and it is no longer offered.
Pushing through post-exertional malaise tends to make ME/CFS worse, which is why graded exercise therapy was withdrawn from the 2021 UK guideline and why pacing is the mainstay.
Cognitive behavioral therapy helps some people cope with a hard illness. On reanalysis it did not change the illness itself, so it belongs as support, not as a cure.
Brain-retraining programs such as DNRS are marketed directly at ME/CFS. The nervous-system sensitization they name is real, but no controlled trial has tested the program itself, and marketing that implies it can reverse the illness runs ahead of the evidence.
No drug changes the course of ME/CFS. The most-watched attempt, the B-cell-depleting drug rituximab, matched placebo in a well-run trial, which closed off a leading disease-modifying hope, though it speaks to one drug rather than every immune approach under study. A small supplement trial of coenzyme Q10 plus NADH is preliminary and industry-affiliated, a possibility to raise with a clinician, not a settled treatment.
Most of care is steady, symptom-by-symptom work:
- Orthostatic intolerance and POTS, one of the more treatable pieces: more fluids and salt where a doctor agrees, compression garments, standing up slowly, and medication a doctor may add.
- Unrefreshing sleep and pain, each treated as a problem in its own right.
- Aids, help at home, and adjustments at work or school that fit a fluctuating illness.
- Anything that adds to the load, such as thyroid disease, sleep apnea, or low mood, found and treated.
Be wary of the marketplace of unregulated "chronic fatigue" supplement protocols and private tests sold online, which charge a vulnerable group for approaches that have not been shown to work.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Energy And Fatigue
Rituximab worked no better than placebo (26.0% vs 35.1% response) in a 151-patient trial
A well-run trial of rituximab, a drug that depletes immune B cells, found it worked no better than placebo for ME/CFS, closing off one of the most-watched attempts at a treatment that changes the disease.
In a randomized, double-blind, placebo-controlled multicenter trial of 151 patients meeting Canadian criteria, rituximab produced an overall response rate of 26.0% versus 35.1% for placebo (difference -9.2 percentage points, 95% CI -23.3 to 5.5), and the groups did not differ in fatigue score over 24 months or on any secondary measure. Serious adverse events occurred in 26% of the rituximab group and 19% of the placebo group. Measured in: 151 adults aged 18 to 65 with ME/CFS by Canadian consensus criteria, ill for 2 to 15 years, at five Norwegian hospitals. This was a well-powered, blinded trial, so the null result is firm for rituximab, but it applies to this one drug and does not rule out other immune approaches under study; the primary outcome was self-reported.
Who this may not transfer to:Both sexes were enrolled with a female majority typical of ME/CFS; the trial did not report sex-stratified response rates.
The study · 1
Fluge et al., B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial · Ann Intern Med 2019;170(9):585-93
Across 8 trials in 1,518 adults, exercise therapy probably eased fatigue a little, on low-to-moderate certainty
Pooled trials found that graded exercise probably lowered fatigue a little compared with doing nothing, but the certainty was low, whether it caused harm was unclear, and most trials did not specifically enroll people with the crash-after-effort pattern.
A Cochrane review of 8 randomized trials in 1,518 adults found that exercise therapy, mostly graded aerobic activity, probably reduced fatigue at the end of treatment compared with passive control, on low-to-moderate certainty evidence. The review judged the effect on serious harms to be uncertain, and most included trials recruited under broad criteria that did not require post-exertional malaise. Measured in: 1,518 adults with a primary diagnosis of chronic fatigue syndrome across 8 randomized controlled trials, using a range of diagnostic criteria. Most trials used broad definitions that did not require post-exertional malaise, so the results may not describe the people for whom exertion reliably triggers a crash; the review flagged uncertainty about harms, and its own publisher has stated it is being updated.
Who this may not transfer to:Trials enrolled both sexes with a female majority typical of ME/CFS cohorts; the review did not report sex-stratified effects.
The study · 1
Larun et al., exercise therapy for chronic fatigue syndrome · Cochrane Database Syst Rev 2019;10:CD003200
Reanalyzed by its own original protocol, PACE's CBT and graded exercise did no better than the comparison group
When the PACE trial data was analyzed the way its own plan had specified, the recovery and improvement numbers for CBT and graded exercise were far lower than first reported and no better than the comparison group, with any small gains limited to how people rated themselves.
A reanalysis of the PACE trial using its own originally specified protocol found that, after correcting for the planned comparisons, CBT and graded exercise did not significantly outperform the control group on overall improvement, and recovery rates were consistently low and did not differ across groups. Significant effects were almost entirely on self-report measures and did not last beyond two years. Measured in: Reanalysis of data from the 641-patient PACE randomized trial (Oxford criteria), using protocol-specified outcomes obtained through a Freedom of Information request. This is a reanalysis of an existing trial rather than a new study, and it inherits the original trial's design limits, including a broad case definition and unblinded, self-reported primary outcomes; those same features are why the authors caution that the modest self-report gains could reflect reporting bias.
Who this may not transfer to:The underlying PACE trial enrolled both sexes with a female majority; the reanalysis did not report sex-stratified outcomes.
The study · 1
Wilshire et al., rethinking the treatment of chronic fatigue syndrome: a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT · BMC Psychol 2018;6(1):6
The structured pacing program in PACE did no better than specialist care at 52 weeks
The specific structured pacing program tested in the main trial did no better than usual specialist care, which is a separate question from the day-to-day energy management that patients and current guidance describe as pacing.
In the PACE randomized trial of 641 patients, the formal protocol tested as adaptive pacing therapy, added to specialist medical care, did not improve fatigue or physical function more than specialist medical care alone at 52 weeks. Measured in: 641 adults meeting Oxford criteria for chronic fatigue syndrome, recruited from six UK secondary-care clinics. Adaptive pacing therapy as manualized in this trial is not the same thing as the individualized energy management now called pacing, so this null result speaks to one formal protocol rather than to the general approach; the trial also used the broad Oxford definition, which does not require post-exertional malaise.
Who this may not transfer to:Both sexes were enrolled with a female majority; the trial did not report sex-stratified primary outcomes.
The study · 1
White et al., comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial · Lancet 2011;377(9768):823-36
In an 80-person trial, coenzyme Q10 plus NADH lowered exercise heart rate and eased fatigue over 8 weeks
In a small trial, a coenzyme Q10 and NADH supplement lowered the heart rate people hit during an exercise test and eased their sense of fatigue over eight weeks, though it did nothing for pain or sleep.
In an 8-week, randomized, double-blind, placebo-controlled proof-of-concept trial of 80 patients, coenzyme Q10 plus NADH significantly lowered the maximum heart rate reached during a cycle exercise test at week 8 (P=0.022) and reduced perceived fatigue versus placebo (P=0.03). Pain and sleep did not improve. The combination was well tolerated. Measured in: 80 adults with chronic fatigue syndrome in a single-center trial in Barcelona. The trial was small, ran only eight weeks, and its main endpoint was a heart-rate measure during exercise rather than day-to-day function, so the finding is preliminary; one author was affiliated with a nutrition company.
Who this may not transfer to:Both sexes were enrolled with a female majority; the trial did not report sex-stratified effects.
The study · 1
Castro-Marrero et al., effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome: a randomized, controlled, double-blind trial · Clin Nutr 2016;35(4):826-34
Measurement And Diagnosis
About 0.89% of people have ME/CFS, women 1.5 to 2 times as often as men
About 0.9 in 100 people are estimated to have ME/CFS under the usual criteria, and women are affected around one and a half to two times as often as men, though the figure shifts a lot depending on how it is counted.
A meta-analysis of 46 studies covering more than 1,085,000 people estimated the prevalence of ME/CFS at 0.89% under the most commonly used case definition (CDC-1994), with a random-effects meta-analysis estimate across all definitions of 0.68% (95% CI 0.48 to 0.97). Estimates varied widely by case definition and by how the diagnosis was ascertained, from 0.09% by physician diagnosis to 1.14% by interview. Women were affected roughly 1.5 to 2 times as often as men. Measured in: More than 1,085,000 participants from community-based surveys and primary care sites across 46 studies published from 1980 to 2018. The estimates ranged widely with the case definition and diagnostic method used, so no single prevalence figure is definitive; the authors note the lack of an objective diagnostic test as the main reason for the spread.
Who this may not transfer to:Both sexes were included; the review found women affected about 1.5 to 2 times as often as men across every subgroup analyzed.
The study · 1
Lim et al., systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) · J Transl Med 2020;18(1):100
19 of 42 people with lasting post-COVID fatigue met the full ME/CFS criteria
In a study of people still exhausted six months after a mild or moderate COVID infection, nearly half met the full criteria for ME/CFS, including the crash after exertion, showing that the illness can be triggered by COVID much as it can follow other infections.
In a prospective cohort of 42 people with persistent moderate-to-severe fatigue and exertion intolerance six months after mild-to-moderate COVID-19, 19 met the 2003 Canadian consensus criteria for ME/CFS, including post-exertional malaise. The post-COVID ME/CFS group resembled a matched cohort whose ME/CFS had followed other infections. Measured in: 42 adults (29 women, 13 men, median age 36.5) with persistent post-COVID fatigue, compared with an age- and sex-matched post-infectious non-COVID ME/CFS cohort. What could explain it instead: People who volunteer for a post-COVID fatigue study are selected for severity, so the share meeting ME/CFS criteria here is likely higher than among all people who catch COVID; unmeasured prior health differences could also shape who develops lasting symptoms.. This is a small observational cohort from the first pandemic wave, so the proportion who develop ME/CFS after COVID cannot be generalized from it; it establishes that the overlap is real rather than measuring how common it is.
Who this may not transfer to:Both sexes were included (29 women, 13 men); the cohort was too small for reliable sex-stratified analysis.
The study · 1
Kedor et al., a prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity · Nat Commun 2022;13(1):5104
How it works
A second exercise test a day later exposes a drop that sorts ME/CFS from controls with 95.1% accuracy
People with ME/CFS did as well as healthy but inactive people on an exercise test the first day, but a day later their bodies could not repeat it, a measurable drop that gives the crash after exertion a physical marker a single test would miss.
In a two-day cardiopulmonary exercise test, 51 women with ME/CFS and 10 sedentary control women performed alike on day one, but on day two the ME/CFS group reached significantly lower oxygen consumption and workload at both peak effort and the anaerobic threshold, while controls reproduced their results. A classification model separated the groups with 95.1% accuracy on the second test. A separate study likewise found ME/CFS patients unable to reproduce their peak oxygen uptake on the second day. Measured in: 51 women with ME/CFS and 10 sedentary control women, each completing two maximal exercise tests 24 hours apart. What could explain it instead: Deconditioning from inactivity could in principle lower exercise capacity, but the control group was also sedentary and reproduced their day-one results, which points away from deconditioning alone as the explanation for the day-two drop.. Only patients well enough to complete two maximal exercise tests were included, so this cannot describe the more severely affected, and the control group was small. It documents a physiological pattern rather than establishing a cause of the illness.
Who this may not transfer to:The Snell cohort was all women; the companion study by Keller included men and women and found the same failure to reproduce peak oxygen uptake on the second day, so the pattern is not thought to be specific to women.
The studies · 2
Snell et al., discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome · Phys Ther 2013;93(11):1484-92
Keller et al., inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment · J Transl Med 2014;12:104
A caution on exercise
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Graded exercise worsened symptoms for 54% to 74% of patients surveyed, while pacing helped 44% to 82%
Across a primary survey of 1,428 patients and comparison surveys totaling 16,665 more, graded exercise therapy was followed by a worsening of symptoms in 54% to 74% of respondents. Cognitive behavioral therapy helped a small share (8% to 35%). Pacing was the most favored approach, with the lowest rate of reported harm and the highest reported benefit (44% to 82%). Survey data captures what patients report after the fact rather than a controlled comparison, so it cannot measure effect size precisely; even so, the size and consistency of the harm signal for graded exercise across independent surveys is what current guidance weighed.Geraghty et al., ME/CFS patients' reports of symptom changes following CBT, GET and pacing treatments: analysis of a primary survey compared with secondary surveys
Do not push through the fatigue
The instinct to exercise your way back to fitness is the one that backfires here. In ME/CFS, structured graded exercise made a large share of people worse, and current guidance no longer recommends it as a treatment. Staying within your energy envelope and pacing to avoid post-exertional crashes is the approach that holds up. This is the opposite of the advice that helps ordinary deconditioning, which is why the distinction matters so much.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
How It Works
The crash has a measurable physical basis. On a maximal exercise test repeated on two days running, people with ME/CFS perform much like healthy but inactive people on the first day, then cannot repeat it on the second, reaching lower oxygen consumption and workload at both peak effort and the anaerobic threshold. Healthy sedentary controls reproduce their day-one results. That gap gives post-exertional malaise a physiological signature a single test would miss, and it points away from simple deconditioning, since the control group was also inactive yet recovered normally.
ME/CFS often begins after an infection, which is why the picture is so often post-viral. COVID made the overlap visible: among people still exhausted six months after a mild or moderate infection, a large share met the full 2003 Canadian consensus criteria for ME/CFS, post-exertional malaise included, and they resembled people whose illness had followed other infections. What triggers the illness in a given person, and the immune and metabolic mechanisms behind the crash, are still being worked out, which is one reason no drug has yet succeeded.
When to Get Checked
When to See Someone
Most of living with ME/CFS is steady, day-to-day energy management, and much of it you manage yourself once the diagnosis is clear. A few situations call for a professional, and one comes first: this is a diagnosis a doctor should make after ruling out other causes, so a full assessment matters before you settle on it. These are the signs to get seen about:
- A first assessment you have not yet had: months of these symptoms deserve a doctor who can rule out anemia, thyroid disease, sleep apnea, celiac disease and other treatable causes before ME/CFS is settled on
- Fatigue alongside unexplained weight loss, a fever that will not settle, drenching night sweats, or a new lump, which points toward a cause that needs looking into promptly(seek urgent care)
- A steep, lasting deterioration, or very severe illness where someone cannot take in enough food or fluid, which needs prompt medical help rather than waiting it out(seek urgent care)
- Fainting, chest pain, or a new or severe pounding or racing heart, which is worth assessing rather than assuming it is only orthostatic intolerance(seek urgent care)
- New or worsening neurological symptoms such as weakness in a limb, loss of coordination, double vision or trouble speaking, which are not part of ME/CFS and need review(seek urgent care)
- Thoughts of harming yourself or ending your life, which is a crisis that needs a person now: contact your local emergency number or the crisis line your health service publishes, and tell someone nearby(seek urgent care)
- Low mood or anxiety weighing on you, which is common alongside a disabling illness and deserves care in its own right, not something to carry alone
- Any plan to start or stop a prescribed medicine because of something on this page; those changes belong with the person who prescribed it
None of this is meant to alarm you. ME/CFS is a serious illness, and it is also one where the daily work is largely yours to manage: learning your energy limit, staying inside it, and treating the sleep, orthostatic and pain symptoms one at a time can make a hard illness more livable. A doctor confirming the diagnosis and ruling out other causes is where it starts, and any decision about medication is a conversation with the person who prescribes it, which is exactly where it belongs.
The Chinese Medicine View
The Chinese Medicine View
Chinese medicine reads a long, depleting illness like this as a vacuity pattern, a state where the body has been drained of its resources. This is different from a pattern of obstruction, where something is stuck. In many cases it centers on the Spleen, which the tradition holds responsible for making qi from food, and the Kidney, held as the root of deep energy and stamina; a lingering post-viral picture is often read as a pathogen that has not fully cleared, leaving qi and yin depleted. Read the patterns below as an interpretive lens on how a person presents, not as a translation of a diagnosis or a claim about cause. There are places the tradition would hold back: a depleted person is not treated with strong draining, purging or heavily stimulating methods, which can deepen the exhaustion, and the idea that vigorous exercise can restore a depleted person conflicts with the same caution that modern pacing describes. The pattern decides the herbs, so a formula that suits one person can be wrong for the next, and herbs belong with a qualified practitioner and alongside medical assessment, not in place of it.
Heavy, tired limbs, poor appetite, loose stools, bloating after eating, and a foggy head that worsens with effort. The classical direction is to strengthen the Spleen and build qi gently, so the person is not pushed past what they can hold.
A deep, bone-level exhaustion, low back and knee weakness, feeling cold, poor stamina and low drive. The tradition sees the Kidney as the root of reserve energy, and this pattern points to supporting it slowly.
The picture that often follows a viral illness: low-grade feverishness or night sweats, a dry throat, restless unrefreshing sleep, and a crash after exertion. The direction is to clear what lingers while rebuilding qi and yin, and to avoid overtreating a person who is already depleted.
Common Questions
Is ME/CFS a real, physical illness?
Yes. ME/CFS is a real, disabling illness, and the crash after exertion has a measurable physical basis. On a two-day exercise test, people with ME/CFS cannot reproduce their day-one results the next day, a drop that healthy sedentary people do not show and that a classification model detected with 95.1% accuracy. It is diagnosed on its pattern after other causes are ruled out, because there is no single blood test.
If I have ME/CFS, should I exercise?
Treat this carefully, because the standard exercise advice was reversed for a reason. A graded exercise program that steadily pushes you past your limit is no longer recommended: the 2021 UK guideline withdrew it after large patient surveys found it worsened symptoms in most people who tried it and a reanalysis of the trial behind it deflated the recovery claims. The current approach is pacing, staying within your energy envelope so effort does not trigger a crash. Any change in activity is something to work out with a clinician who understands post-exertional malaise.
What is pacing, and how do I start?
Pacing means finding your limit and staying inside it, so you crash less often. A practical start is to track your activity and symptoms for a couple of weeks, notice what reliably brings on a crash and how long the delay is, and then keep daily effort below that threshold, breaking tasks into short spells with rest between. The aim is to spot your own early warning signs and stop before the limit, not after. It does not cure the illness, and in surveys it is the approach people find most helpful and least likely to set them back.
Is there a cure or a drug that works?
No treatment cures ME/CFS, and no drug has changed its course in a proper trial. The most-watched candidate, rituximab, matched placebo in a well-run 151-patient study, with response rates of 26.0% on the drug and 35.1% on placebo. Care is aimed at the symptoms one at a time: unrefreshing sleep, orthostatic problems, and pain. A small trial of coenzyme Q10 plus NADH eased fatigue and lowered exercise heart rate over 8 weeks, which is a possibility to discuss with a clinician rather than a proven treatment.
Can COVID cause ME/CFS?
It can. ME/CFS often follows an infection, and COVID is one of them. In a study of people still severely fatigued six months after a mild or moderate COVID infection, 19 of 42 met the full criteria for ME/CFS, including post-exertional malaise, and looked much like people whose illness had followed other infections. Where the illness began after COVID, the Long COVID page covers the overlapping ground.
Do supplements help?
The evidence is thin. The best-studied combination, coenzyme Q10 plus NADH, lowered the heart rate people reached during an exercise test and eased their sense of fatigue over 8 weeks in one small 80-person trial, while doing nothing for pain or sleep, and one of its authors was affiliated with a nutrition company. It is reasonable to raise with a clinician. What deserves caution is the marketplace of expensive, unregulated "chronic fatigue" protocols and private tests sold online, which charge a vulnerable group for approaches that have not been shown to work.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 10 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.